会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明授权
    • Channel impulse response estimating decision feedback equalizer
    • 信道脉冲响应估计判决反馈均衡器
    • US08320442B2
    • 2012-11-27
    • US10911282
    • 2004-08-04
    • Bruno AmizicMark FimoffJin KimSreenivasa M. Nerayanuru
    • Bruno AmizicMark FimoffJin KimSreenivasa M. Nerayanuru
    • H03H7/30
    • H04L25/03057H04L2025/03382H04L2025/0349
    • A decision feedback equalizer is operated by making first symbol decisions from an output of the decision feedback equalizer such that the first symbol decisions are characterized by a relatively long processing delay, by making second symbol decisions from the output of the decision feedback equalizer such that the second symbol decisions are characterized by a relatively short processing delay, and by determining tap weights for the decision feedback equalizer based on the first and second symbol decisions. The first symbol decisions may be derived from the output of a long traceback trellis decoder. The second symbol decisions may be derived either from the output of a short traceback trellis decoder or from shorter delay outputs of the long traceback trellis decoder.
    • 通过从所述判决反馈均衡器的输出进行第一符号判定来操作判定反馈均衡器,以便通过从所述判决反馈均衡器的输出进行第二符号判定,使得所述第一符号判定由相对长的处理延迟表征,使得 第二符号决定的特征在于相对短的处理延迟,并且通过基于第一和第二符号决定确定用于判决反馈均衡器的抽头权重。 第一符号决定可以从长跟踪网格解码器的输出中导出。 第二符号决定可以从短跟踪网格解码器的输出或长跟踪网格解码器的较短延迟输出中导出。
    • 27. 发明授权
    • Aliphatically modified biodegradable block copolymers as thermogelling polymers
    • 脂肪族改性的生物可降解嵌段共聚物作为热凝胶聚合物
    • US07740877B2
    • 2010-06-22
    • US11784528
    • 2007-04-06
    • Sung Wan KimSeongbong JoJin Kim
    • Sung Wan KimSeongbong JoJin Kim
    • A61F2/02C08G63/08
    • C08L67/04A61K9/0024A61K9/06A61K47/34C08G63/664
    • A thermogelling, aliphatically modified polymer for use in drug delivery is described. Illustrative embodiments include poly(lactic-co-ε-caprolactone)-poly(ethylene glycol)-poly(lactic-co-ε-caprolactone) hexanoate and poly(lactic-co-ε-caprolactone)-poly(ethylene glycol)-poly(lactic-co-ε-caprolactone) laurate. Another illustrative embodiment includes a composition having a thermogelling amount of an aliphatically modified poly(lactic-co-ε-caprolactone)-poly(ethylene glycol)-poly(lactic-co-ε-caprolactone) and an effective amount of a drug. The thermogelling polymers are made by bonding an aliphatic group to poly(lactic-co-ε-caprolactone)-poly(ethylene glycol)-poly(lactic-co-ε-caprolactone). A method of use includes injecting a warm-blooded individual with a thermogelling amount of the aliphatically modified polymer and a drug.
    • 描述了用于药物递送的耐热凝胶,脂质改性聚合物。 说明性实施方案包括聚(乳酸 - 共 - 己内酯) - 聚(乙二醇) - 聚(乳酸 - 共 - 己内酯)己酸酯和聚(乳酸 - 共 - 己内酯) - 聚(乙二醇 ) - 聚(乳酸 - 共 - 己内酯)月桂酸酯。 另一个说明性实施方案包括具有热凝胶量的脂族改性聚(乳酸 - 共 - 己内酯) - 聚(乙二醇) - 聚(乳酸 - 共 - 己内酯)和有效量的药物 。 热胶凝聚合物通过将脂族基团与聚(乳酸 - 共 - 己内酯) - 聚(乙二醇) - 聚(乳酸 - 共 - 己内酯)结合而制备。 一种使用方法包括用热胶凝量的脂质改性聚合物和药物注射温血个体。